http://www.xconomy.com/boston/2007/07/10/no-new-shares-tendered-in-bioenvision-deal-genzyme-still-hopes-for-merger/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 03:54:18 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.xconomy.com/boston/2007/07/10/no-new-shares-tendered-in-bioenvision-deal-genzyme-still-hopes-for-merger/comment-page-1/#comment-51 Robert Buderi Tue, 10 Jul 2007 19:52:55 +0000 http://www.xconomy.com/2007/07/10/no-new-shares-tendered-in-bioenvision-deal-genzyme-still-hopes-for-merger/#comment-51 Just got a call from Genzyme. The company miscounted the shares tendered by this morning's deadline. Instead of the 6,888,098 shares reported tendered, the company actually received 8,706,644--raising its total from 19 percent to 22 percent of the common stock counting converted preferred shares. However, that is still down 4 percent from the original tender deadline on July 2, meaning a significant number of withdrawals took place. Just got a call from Genzyme. The company miscounted the shares tendered by this morning’s deadline. Instead of the 6,888,098 shares reported tendered, the company actually received 8,706,644–raising its total from 19 percent to 22 percent of the common stock counting converted preferred shares. However, that is still down 4 percent from the original tender deadline on July 2, meaning a significant number of withdrawals took place.

]]>